Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Respiratory syncytial virus (RSV) causes symptoms similar to the common cold. But in older adults and those with certain medical conditions, the virus can increase the risk of serious illnesses.

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial virus prophylaxis, with uptake varying by race and other social factors.

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private ...

Palivizumab, when given through the veins or into a muscle (systemically), reduces hospitalisations due to respiratory syncytial virus (RSV) and reduces respiratory problems later on (chest wheezing), ...

Respiratory syncytial virus (RSV) affects infants, young children, and older adults, particularly those with compromised respiratory or cardiovascular health. Every year RSV causes approximately ...

The Centers for Disease Control and Prevention’s (CDC) health advisory on the respiratory syncytial virus (RSV) issued Friday brings the focus to a disease that many may not have familiarity ...

Respiratory syncytial virus (RSV) is a common germ that can settle into your lungs and airways. It's the top cause of upper respiratory infection in babies and toddlers, but anyone can get it.

March 3, 2022 / 1:33 PM EST / CBS Boston BOSTON (CBS) -- Help may soon be on the way to protect healthy infants from a common and sometimes life-threatening respiratory virus.